Key Insights

Highlights

Treatment Research

3 treatments under study, led by Skin Biopsy

Research Leaders

5 sponsors active, led by Institut National de la Santé Et de la Recherche Médicale, France

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Recruiting3
Not Yet Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials
NCT03058185RecruitingPrimary

Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies)

NCT05394506Not ApplicableRecruitingPrimary

Modifying Factors in Striated Muscle Laminopathies

NCT06813443Recruiting

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

SYF0c91d4255ace459e929797c6757cdad3Phase 2Not Yet Recruiting

Deflazacort TREATment in LMNArelated

Showing all 4 trials

Research Network

Common Treatments

  • Skin Biopsy1
  • Deflan 2275 Mgml Gocce Orali Sospensione1
  • Muscle Biopsy1

Active Sponsors

  • Institut National de la Santé Et de la Recherche Médicale, France2
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna1
  • Pitié-Salpêtrière Hospital1
  • Institut de Myologie, France1
  • Assistance Publique - Hôpitaux de Paris1

Top Investigators

Related Conditions

  • Mitochondrial Cardiomyopathy1
  • Micro Rna1
  • Amyloidosis Cardiac1
  • Dilated Cardiomyopathy1a1
  • Echocardiogram1

Activity Timeline